Airway disease and inhaled corticosteroids (ICS) in children with primary ciliary dyskinesia (PCD)

Eleonora Dehlink (London, United Kingdom), Eleonora Dehlink, Charlotte Richardson, Gemma Marsh, Kiri Pares, Angela Jamalzadeh, Andy Bush, Claire Hogg, Siobhán B. Carr

Source: International Congress 2016 – Paediatric respiratory infection
Session: Paediatric respiratory infection
Session type: Poster Discussion
Number: 1601
Disease area: Airway diseases, Paediatric lung diseases

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
Eleonora Dehlink (London, United Kingdom), Eleonora Dehlink, Charlotte Richardson, Gemma Marsh, Kiri Pares, Angela Jamalzadeh, Andy Bush, Claire Hogg, Siobhán B. Carr. Airway disease and inhaled corticosteroids (ICS) in children with primary ciliary dyskinesia (PCD). Eur Respir J 2016; 48: Suppl. 60, 1601

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Dysphonia in asthmatic women using inhaled corticosteroids: It is not only a laryngeal inflammation
Source: International Congress 2016 – Novel mechanisms and treatment modalities in asthma
Year: 2016


Airway hyperresponsiveness (AHR) to mannitol following regular inhaled corticosteroids (ICS) in Australian army and police recruits
Source: International Congress 2015 – Exploring mechanisms in obstructive airway diseases
Year: 2015


Induced sputum in children With persistent asthma: The effect to inhaled corticosteroid treatment
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Nasal disease in chronic severe asthma (CSA) and eosinophilic granulomatosis with poliangiitis (EGPA)
Source: International Congress 2015 – Co-existing diseases and asthma
Year: 2015


The effect of treatment duration by inhaled glucocorticosteroids, on “cough variant asthma” in children
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013

Wet cough in paediatric severe therapy resistant asthma (STRA)
Source: International Congress 2016 – Paediatric asthma: recurrent, persistent, or severe obstruction and lung function techniques
Year: 2016

Study of some inflammatory markers in children with moderate persistent bronchial asthma before and after therapy with inhaled corticosteroids
Source: Annual Congress 2013 –Monitoring asthma: genes, cells and molecules
Year: 2013

Clinical experience with montelukast plus ICS vs. only ICS in non-asthmatic eosinophilic bronchitis (NAEB) in Indian patients
Source: International Congress 2016 – Pharmacological intervention in humans and murine models of asthma
Year: 2016


FeNO in children with asthma is related to inhaled corticosteroids adherence, not to asthma control
Source: International Congress 2014 – Paediatric asthma: markers and molecules
Year: 2014

Changes in symptoms, respiratory function, airway inflammation, and airway hyperresponsiveness over 10 year of inhaled corticosteroid therapy in adult asthma patients
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015


Validation of the ’test of the adherence to inhalers’ (TAI) for asthma and COPD patients
Source: International Congress 2015 – Is asthma always an easy disease to diagnose and manage?
Year: 2015


Duration of inhaled corticosteroid therapy in children with asthma and frequency of community-acquired pneumonia in them
Source: International Congress 2016 – Drugs, bugs, BMI, and other problems in paediatric asthma
Year: 2016

Influence of basic therapy of bronchial asthma (BA) on respiratory symptoms in patients with pulmonary TB associated with bronchial asthma
Source: International Congress 2014 – Tuberculosis: from epidemiology to therapy 1
Year: 2014

Indirect comparison of bronchial thermoplasty (BT) versus omalizumab (OM) for severe uncontrolled asthma
Source: International Congress 2015 – New data on established treatments for asthma and COPD
Year: 2015

Clinical characteristics, pulmonary function, and response to beta2-agonist: Patients with asthma vs. patients with asthma/COPD overlap syndrome
Source: Annual Congress 2013 –Asthma at the bedside
Year: 2013


Airway hyperresponsiveness (AHR) of small airways assessed by impulse oscillation (IOS) in adult asthma
Source: International Congress 2015 – Asthma mechanisms and management
Year: 2015

Differences between asthma-COPD overlap syndrome (ACOS) and adult-onset asthma
Source: International Congress 2016 – Phenotyping asthma
Year: 2016


Factors associated with uncontrolled asthma in patients with aspirin-exacerbated respiratory disease (AERD)
Source: International Congress 2014 – Asthma: still a heterogeneous condition!
Year: 2014


Safety of tiotropium in pre-school children with symptomatic persistent asthma
Source: International Congress 2016 – Paediatric asthma: lessons learned from studies with large sample sizes and multi-centre drug studies
Year: 2016


Once-daily inhaled corticosteroids in children with asthma: Not a simple solution for non-adherence
Source: Annual Congress 2013 –Asthma treatment and management in children
Year: 2013